Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Condition: Melanoma Intervention: Drug: Fluzoparib Camrelizumab Temozolomide Sponsor: Peking University Cancer Hospital & Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials